29 results
10-12G/A
EX-10.1
ATXI
Avenue Therapeutics Inc
13 Mar 17
Registration of securities (amended)
12:00am
at its sole cost and expense.
1.27 “European Union” means the member states of the European Union as of the Effective Date.
1.28 “Effective Date” shall … such as the European Union) necessary to Commence human clinical trials in such jurisdiction, and including all regulations at 21 C.F.R. § 312 et. esq
10-12G
EX-10.1
ATXI
Avenue Therapeutics Inc
12 Jan 17
Registration of securities
12:00am
sole cost and expense.
1.27 “European Union” means the member states of the European Union as of the Effective Date.
1.28 “Effective Date” shall have … Union) necessary to Commence human clinical trials in such jurisdiction, and including all regulations at 21 C.F.R. § 312 et. esq., and equivalent
10-12G/A
EX-10.1
ATXI
Avenue Therapeutics Inc
18 Feb 16
Registration of securities (amended)
12:00am
by Coronado at its sole cost and expense.
1.27 “European Union” means the member states of the European Union as of the Effective Date.
1.28 “Effective Date … such as the European Union) necessary to Commence human clinical trials in such jurisdiction, and including all regulations at 21 C.F.R. § 312 et
8-K
EX-10.1
rfyfibiakqyyk x36
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
424B3
ranaxkv6mnte
2 Feb 24
Prospectus supplement
12:00am
424B5
r0h8drv3d
10 May 24
Prospectus supplement for primary offering
4:52pm
8-K
EX-10.2
565y ikvqq6
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-1.1
vo67fm aic
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
PREM14A
ep3byc
11 Dec 18
Preliminary proxy related to merger
5:23pm
DEFM14A
pi28ec5on
21 Dec 18
Proxy related to merger
12:23pm